-
Je něco špatně v tomto záznamu ?
A New Caco-2 Cell Model of in Vitro Intestinal Barrier: Application for the Evaluation of Magnesium Salts Absorption
J. Kyselovič, N. Chomanicová, A. Adamičková, S. Valášková, B. Šalingová, A. Gažová
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
PubMed Central
od 2020
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- Caco-2 buňky MeSH
- hořčík metabolismus MeSH
- lidé MeSH
- střevní sliznice metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Experimental data concerning the bioavailability of the different Mg-salts in human organism is inconsistent. Mg-absorption reported by clinical studies largely varies depending on the method used for evaluation. The aim of this study was to evaluate the bioavailability and accessibility of magnesium bound in different Mg-salt compounds, using an in vitro model of intestinal cell barrier. The study included a variety of inorganic (oxide, sulphate, chloride, carbonate) and organic salts (lactate, citrate, pidolate). Caco-2 cells were cultivated in a complete culture medium with different magnesium salts treatments in ascending concentrations. The viability and quantity of cells was analysed by FACS. Mg-absorption was analysed by a direct colorimetric assay, measured by spectrometry. T-test identified a significant decrease in cell count treatment with mg-lactate compared with citrate. Mg-pidolate showed a significantly higher cell viability compared with Mg-citrate, Mg-lactate and Mg-chloride. Even though the difference was not significant, we showed that an increase in Mg2+ salt concentration progressively decreased the cell count and the viability and the effect was universal for all the used Mg-salt treatments. Mg-citrate, chloride, and sulphate showed a significantly lower absorption compared to Mg-carbonate, pidolate and oxide. Our in vitro monolayer model of human intestinal transport showed that viability and quantity of cell decreased with increasing Mg-concentration. We admit that our experiment model may have some limitations in accurately describing an in vivo Mg2+ absorption. Moreover, it is also necessary to assess the relevance of our data in vivo and especially in clinical practice.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22009458
- 003
- CZ-PrNML
- 005
- 20250627092558.0
- 007
- ta
- 008
- 220419s2021 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.934772 $2 doi
- 035 __
- $a (PubMed)34918527
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Kyselovič, Ján, $d 1963- $u 5th Department of Internal Medicine, Faculty of Medicine, Comenius University Bratislava, Slovakia $7 xx0082943
- 245 12
- $a A New Caco-2 Cell Model of in Vitro Intestinal Barrier: Application for the Evaluation of Magnesium Salts Absorption / $c J. Kyselovič, N. Chomanicová, A. Adamičková, S. Valášková, B. Šalingová, A. Gažová
- 520 9_
- $a Experimental data concerning the bioavailability of the different Mg-salts in human organism is inconsistent. Mg-absorption reported by clinical studies largely varies depending on the method used for evaluation. The aim of this study was to evaluate the bioavailability and accessibility of magnesium bound in different Mg-salt compounds, using an in vitro model of intestinal cell barrier. The study included a variety of inorganic (oxide, sulphate, chloride, carbonate) and organic salts (lactate, citrate, pidolate). Caco-2 cells were cultivated in a complete culture medium with different magnesium salts treatments in ascending concentrations. The viability and quantity of cells was analysed by FACS. Mg-absorption was analysed by a direct colorimetric assay, measured by spectrometry. T-test identified a significant decrease in cell count treatment with mg-lactate compared with citrate. Mg-pidolate showed a significantly higher cell viability compared with Mg-citrate, Mg-lactate and Mg-chloride. Even though the difference was not significant, we showed that an increase in Mg2+ salt concentration progressively decreased the cell count and the viability and the effect was universal for all the used Mg-salt treatments. Mg-citrate, chloride, and sulphate showed a significantly lower absorption compared to Mg-carbonate, pidolate and oxide. Our in vitro monolayer model of human intestinal transport showed that viability and quantity of cell decreased with increasing Mg-concentration. We admit that our experiment model may have some limitations in accurately describing an in vivo Mg2+ absorption. Moreover, it is also necessary to assess the relevance of our data in vivo and especially in clinical practice.
- 650 _2
- $a Caco-2 buňky $7 D018938
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a střevní sliznice $x metabolismus $7 D007413
- 650 _2
- $a hořčík $x metabolismus $7 D008274
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sabová, Nikola, $d 1993- $7 xx0267320 $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University Bratislava, Slovakia
- 700 1_
- $a Samáková, Adriana, $d 1993- $7 xx0267319 $u 5th Department of Internal Medicine, Faculty of Medicine, Comenius University Bratislava, Slovakia
- 700 1_
- $a Valášková, Simona, $d 1985- $7 xx0302182 $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University Bratislava, Slovakia
- 700 1_
- $a Šalingová, Barbara $7 xx0333146 $u 5th Department of Internal Medicine, Faculty of Medicine, Comenius University Bratislava, Slovakia
- 700 1_
- $a Gažová, Andrea, $d 1980- $7 xx0255822 $u Institute of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Comenius University Bratislava, Slovakia
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 70, Suppl. 1 (2021), s. S31-S41
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34918527 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y p $z 0
- 990 __
- $a 20220419 $b ABA008
- 991 __
- $a 20250627092550 $b ABA008
- 999 __
- $a ok $b bmc $g 1796966 $s 1160656
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 70 $c Suppl. 1 $d S31-S41 $e 20211130 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK124 $a Pubmed-20220419
